Home › Funds › BlackRock Inc › NMRA
BlackRock Inc position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)7.79M sh
Reported value held$13.25M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 6.19M | $81.73M | New |
| Q4 2024 | 7.11M | $75.33M | Add |
| Q1 2025 | 6.35M | $6.35M | Reduce |
| Q1 2025 | 6.35M | $6.35M | Reduce |
| Q2 2025 | 2.88M | $2.11M | Reduce |
| Q2 2025 | 2.88M | $2.11M | Reduce |
| Q3 2025 | 1.82M | $3.30M | Reduce |
| Q4 2025 | 2.02M | $3.62M | Add |
| Q1 2026 | 2.05M | $4.01M | Add |
| Q2 2026 | 7.79M | $13.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026
- Goldman Sachs Group 303.86K sh · $516.57K · Q2 2026